ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

MRNJ Metatron Inc (PK)

0.0001
0.00 (0.00%)
27 Nov 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Metatron Inc (PK) USOTC:MRNJ OTCMarkets Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.0001 0.0001 0.0001 0.0001 0.0001 0.0001 10,113,100 00:00:00

Metatron Apps Unveils "Dr. AI" Health Assistant for Personalized Health Support

23/01/2024 1:23pm

InvestorsHub NewsWire


Dover, DE -- January 23, 2024 -- InvestorsHub NewsWire -- Metatron Apps Inc. (OTC: MRNJ), a pioneer in digital technology, is thrilled to usher in the new year with a groundbreaking development. We are proud to announce the launch of Dr. AI app, a state-of-the-art health assistant application designed to transform personal healthcare.

 

Free for a limited time access Dr. AI on the OpenAI GPT Store: https://bit.ly/MetatronappsDrAI

 

The worldwide market for artificial intelligence in healthcare, valued at USD 16.3 billion in 2022, is forecasted to experience a robust growth rate of 40.2% CAGR, projecting it to reach an impressive USD 173.55 billion by 2029. This sector is witnessing a substantial and noteworthy increase in both its expansion and adoption.

 

The Dr. AI Health Assistant App offers a variety of practical use cases to enhance healthcare management and support. It includes features for symptom analysis, offering preliminary diagnoses based on user-inputted symptoms, and reminders to ensure adherence to treatment schedules. The app also provides personalized health tips and wellness recommendations, catering to individual user needs.

 

The introduction of Dr. AI app marks our continued dedication to driving digital innovation with AI-centered solutions, showcasing our commitment to enhancing everyday life through technology.

 

Also in the pipeline, Fanfinder.ai, leverages advanced AI for content personalization and exposure on TikTok, enhancing user and creator experiences. The app will offer a premium subscription for advanced features and targeted traffic for creators, reflecting the business models of tech leaders like NVIDIA and Google. Set for a beta release on MetatronAI.com, with an alpha version expected in 2024, Fanfinder.ai bolsters Metatron's reputation as an AI technology innovator, joining its suite of applications like StockTrendz and LegalEaze.

 

Disclaimer: Dr AI Medical App is designed to provide health-related information and support and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider for any medical concerns or conditions

 

Metatron's tradition of innovation continues with these AI app releases. As we embark on this new phase, we remain committed to reshaping the AI landscape and delivering top-notch digital solutions. Stay tuned for more exciting updates from Metatron Apps Inc.

 

Contact: IR@Metatronapps.com

 

AI website: MetatronAI.com

Dr. AI app: https://bit.ly/MetatronappsDrAI

Apple App: https://apple.co/3nibweB

Android App: https://bit.ly/40XOglu

Corporate website: MetatronApps.com

Twitter: https://twitter.com/MetatronInc

TIk-Tok: https://www.tiktok.com/@metatronai.com

 

Metatron Apps Inc.

160 Greentree Drive Suite 101

Dover, DE 19904

(302) 489-4016

 

Disclaimer: Our Legal Translation service is a helpful tool, but it is not a substitute for professional legal advice.

 

Note: Metatron Apps Inc. and FanFinderAI are independent entities and are not affiliated with or endorsed by OnlyFans or TikTok, which are trademarks of their respective owners.

 

Forward-Looking Statements: Any statements made in this press release which are not historical facts contain certain forward-looking statements, as such term is defined in the Private Litigation Reform Act of 1995, concerning potential developments affecting the business, prospects, financial condition and other aspects of the company to which this release pertains. These forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results of the specific items described in this release, and the company's operations generally, to differ materially from what is projected in such forward-looking statements. Although such statements are based upon the best judgments of management of the company as of the date of this release, significant deviations in magnitude, timing and other factors may result from business risks and uncertainties including, without limitation, the company's need for additional financing, which is not assured and which may result in dilution of shareholders, the company's status as a small company with a limited operating history, dependence on third parties and the continuing popularity of the iOS operating system, general market and economic conditions, technical factors, receipt of revenues, and other factors, many of which are beyond the control of the company. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance, or achievements. Moreover, neither we nor any other person assumes responsibility for the accuracy and completeness of such statements, and we disclaim any obligation to update information contained in any forward-looking statement.

 

 

 

1 Year Metatron (PK) Chart

1 Year Metatron (PK) Chart

1 Month Metatron (PK) Chart

1 Month Metatron (PK) Chart

Your Recent History

Delayed Upgrade Clock